EMEA-001999-PIP02-17-M01
Table of contents
Key facts
| Active substance |
Cenicriviroc
|
| Therapeutic area |
Gastroentology-Hepatology
|
| Decision number |
P/0356/2020
|
| PIP number |
EMEA-001999-PIP02-17-M01
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of non-alcoholic steatohepatitis (NASH)
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Allergan Pharmaceuticals International Limited
E-mail: UK_Medinfo@allergan.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|